Primary and secondary immune deficiencies of domestic animals

Ill thrift and juvenile llama immunodeficiency syndrome

The problem of "ill thrift" or "failure to thrive" in juvenile llamas is widespread and relatively common in the continental United States. Juvenile llama immunodeficiency syndrome (JLIDS) is one of several causes of the problem and is the most common cause of ill thrift in juvenile llamas evaluated at Colorado State University's Veterinary Teaching Hospital. This article will review current knowledge of JLIDS and will briefly discuss other causes of ill thrift in juvenile llamas.

Biological half-life of ovine antibody in neonatal lambs and adult sheep following passive immunization

Neonatal lambs and adult wethers were passively immunized with ovine antibody directed against ovalbumin or Brucella abortus. Estimates for the biological half-lives of the antibodies ranged from 18 to 24 days in neonatal lambs and 12 to 17 days in adult wethers. The evidence suggested that both normal and immunosuppressed wethers which were passively immunized with serum antibody catabolized this antibody at a faster rate than did neonatal lambs. The data provided no support for the hypothesis that the growth factors and immunomodulatory factors, which are known to be present in colostrum, can influence the biological half-life of homologous antibody following passive immunization.

Hematology, blood typing, and immunology of the neonatal foal

Hematologic parameters change during the first 10 days of life. Erythrocytes increase in number but decrease in size and hemoglobin concentration. The PCV, hemoglobin, and platelet count also decrease. Total blood and plasma volume and, to lesser extent, erythrocyte volume decrease. Normal neonatal foals may have immature neutrophils (up to 5 per cent bands), and their early rapid rise in neutrophil numbers may be accompanied by a lymphopenia. Monocytes, eosinophils, and basophils are all absent or low initially. Infectious processes can cause rapid and variable changes in the leukogram. However, elevation of fibrinogen levels may lag behind the development of an inflammatory process, and this parameter should not be relied on for early evidence of infection. After 12 hours of life, there is generally a decrease in serum concentrations of Na, Cl, iron, creatinine, BUN, plasma protein, and possibly calcium. LDH, SAP, P, bilirubin, and glucose concentrations are all higher in foals than in mature horses. Creatinine may actually be elevated during the first 12 hours of life and then decreases. If azotemia, hypochloremia, hyponatremia, and hyperkalemia are found, ruptured bladder with uroperitoneum should be suspected. The creatinine concentration is preferable to BUN determination for diagnosis of this condition. Blood typing is useful for diagnosis of NI, determination of blood compatability between donor and transfusion recipient, and for verification of parentage for breed registries. Several techniques are available. Several tests are available for evaluation of the foal's immunoglobulin levels and confirmation of passive antibody transfer. Because foals suffering from FPT are more predisposed to infections, their immunoglobulin status should be determined as early as possible so that additional colostrum or plasma can be administered as needed. Neonatal isoerythrolysis is uncommon but is an important immunologic syndrome that often results in a fatal hemolytic crisis. If one suspects the condition may be likely, the optimal time for testing the mare is during the last 2 weeks of gestation. If the foal's dam is shown to have alloantibodies against a panel of known erythrocyte alloantigens, prevention is possible by feeding colostrum from another mare. If a foal develops NI, further colostrum ingestion from the dam must be prevented. Good nursing care, minimizing stress, and adequate frequent feedings are essential; prophylactic antibiotics should be used, and transfusion may be necessary.

Increased susceptibility of fibroblasts from horses with severe combined immunodeficiency to growth inhibition by 2'-deoxyadenosine

The effect of adenosine, deoxyadenosine, guanosine, and deoxyguanosine on the growth rate of fibroblasts derived from normal horses, horses heterozygous for the severe combined immunodeficiency (SCID) trait (heterozygotes), and horses with SCID was studied. All four purines were found to inhibit growth in a dose-dependent manner, but only adenosine and deoxyadenosine were inhibitory at concentrations of less than 100 microM. No statistical difference in sensitivity to adenosine was detected between normal and SCID fibroblasts. Fibroblasts from SCID horses were, however, more sensitive to the growth inhibitory effects of deoxyadenosine than were fibroblasts from normal horses. Furthermore, following 24 hr of incubation with radiolabeled deoxyadenosine, radiolabeled deoxyATP concentrations were found to be twofold higher in SCID fibroblasts compared to those concentrations measured in normal fibroblasts cultured under identical conditions. Adenosine deaminase and S-adenosylhomocysteine hydrolase activities were normal in SCID fibroblasts. These findings suggest that SCID horses may have a defect in either transport or phosphorylation of deoxyadenosine, or in the utilization of deoxyATP.

An evaluation of contribution derived from investigations of equine immunodeficiencies

Following the descriptions of immunodeficiencies in horses beginning in 1973, there has been considerable effort to develop methods for differential diagnosis and to determine the cause and prevalence of the disorders. In addition, the equine immunodeficiencies, especially combined immunodeficiency, have been studied from a comparative viewpoint with the goal of finding information applicable to similar diseases of children. Coincident with the development of knowledge about the immunodeficiencies per se, considerable information about several aspects of immunology has been obtained. It is the purpose of this review to focus on findings from experiments with equine immunodeficiencies concerning prenatal and neonatal immunology, lymphocyte function, secretory immunity, immunoreconstitution, graft-versus-host reactions and previously unrecognized diseases.